These final results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the concept of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Issues. At that time, Microsoft https://eugenej594mqr3.blogrelation.com/profile